CSS
APYX icon

Cubist Systematic Strategies’s Apyx Medical APYX Stock Holding History

Cubist Systematic Strategies’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,126
Closed -$54.8K – 3552
2023
Q3 		$54.8K Buy
+17,126
New +$79.8K ﹤0.01% 3021
2022
Q4 		– Sell
-12,814
Closed -$58K – 4222
2022
Q3 		$58K Buy
12,814
+437
+4% +$3.13K ﹤0.01% 4109
2022
Q2 		$73K Buy
+12,377
New +$63.5K ﹤0.01% 4029

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Cubist Systematic Strategies's APYX Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Apyx Medical (APYX) in Q4 2023, closing a stake of 17,126 shares — an estimated $54.8K sold.

Cubist Systematic Strategies first reported a position in APYX in Q2 2022 and held it in 3 quarters. The position peaked at $73K in Q2 2022. 62 funds tracked by Wall St. Rank hold APYX as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining Apyx Medical position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 17,126 Apyx Medical shares in Q4 2023, an estimated $54.8K.
  • Cubist Systematic Strategies first reported a position in Apyx Medical in Q2 2022 and held it in 3 quarters.
  • Cubist Systematic Strategies's Apyx Medical position peaked at $73K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.